KLK2 and prostate carcinoma: Data in this paper shows that decreasing LMTK2 expression in prostate cancer cells deprived of androgen results in significantly higher levels of FKBP51 protein as well as increased mRNA levels of AR-dependent genes (KLK2, S100P, TMPRS22 and PSA).